Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase 1 clinical study of cell therapy with effective-mononuclear cells (E-MNC) for radiogenic xerostomia (first-in-human study) (FIH study on E-MNC therapy for radiogenic xerostomia).
Sumita Y, Iwamoto N, Seki M, Yoshida T, Honma R, Iwatake M, Ohba S, Takashi I, Hotokezaka Y, Harada H, Kuroshima S, Nagai K, Asahara T, Atsushi Kawakam I, Asahina I. Sumita Y, et al. Among authors: seki m. Medicine (Baltimore). 2020 Jun 26;99(26):e20788. doi: 10.1097/MD.0000000000020788. Medicine (Baltimore). 2020. PMID: 32590759 Free PMC article.
Anti-inflammatory and vasculogenic conditioning of peripheral blood mononuclear cells reinforces their therapeutic potential for radiation-injured salivary glands.
I T, Sumita Y, Yoshida T, Honma R, Iwatake M, Raudales JLM, Shizuno T, Kuroshima S, Masuda H, Seki M, Tran SD, Asahara T, Asahina I. I T, et al. Among authors: seki m. Stem Cell Res Ther. 2019 Oct 17;10(1):304. doi: 10.1186/s13287-019-1414-7. Stem Cell Res Ther. 2019. PMID: 31623661 Free PMC article.
CD34hi subset of synovial fibroblasts contributes to fibrotic phenotype of human knee osteoarthritis.
Miyahara J, Omata Y, Chijimatsu R, Okada H, Ishikura H, Higuchi J, Tachibana N, Nagata K, Tani S, Kono K, Kawaguchi K, Yamagami R, Inui H, Taketomi S, Iwanaga Y, Terashima A, Yano F, Seki M, Suzuki Y, Baron R, Tanaka S, Saito T. Miyahara J, et al. Among authors: seki m. JCI Insight. 2025 Jan 23;10(2):e183690. doi: 10.1172/jci.insight.183690. JCI Insight. 2025. PMID: 39846253 Free article.
SLC9A6-Linked Parkinson Syndrome in Female Heterozygotes Is Associated With PET-Detectable Tau Pathology.
Yamamoto Y, Takahata K, Seki M, Okusa S, Tatebe H, Ueda R, Endo H, Tagai K, Moriguchi S, Kurose S, Ichihashi M, Matsuura S, Kawamura K, Zhang MR, Ueno Y, Takiyama Y, Tokuda T, Higuchi M, Ito D. Yamamoto Y, et al. Among authors: seki m. Neurol Genet. 2025 Jan 13;11(1):e200235. doi: 10.1212/NXG.0000000000200235. eCollection 2025 Feb. Neurol Genet. 2025. PMID: 39810750 Free PMC article.
Levodopa Pharmacokinetics in Switching from Levodopa/Carbidopa Intestinal Gel to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient with Parkinson's Disease: a case report.
Nukariya T, Tezuka T, Okusa S, Okochi R, Sakai Y, Nihei Y, Nakahara J, Seki M. Nukariya T, et al. Among authors: seki m. J Mov Disord. 2025 Jan 6. doi: 10.14802/jmd.24247. Online ahead of print. J Mov Disord. 2025. PMID: 39757596 Free article. No abstract available.
2,194 results